Synchrony Financial (SYF)
(Delayed Data from NYSE)
$55.25 USD
+0.11 (0.20%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $55.24 -0.01 (-0.02%) 7:58 PM ET
1-Strong Buy of 5 1
A Value C Growth C Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$55.25 USD
+0.11 (0.20%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $55.24 -0.01 (-0.02%) 7:58 PM ET
1-Strong Buy of 5 1
A Value C Growth C Momentum A VGM
Zacks News
Virtu Financial (VIRT) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Virtu Financial (VIRT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Unveiling Synchrony (SYF) Q4 Outlook: Wall Street Estimates for Key Metrics
by Zacks Equity Research
Besides Wall Street's top -and-bottom-line estimates for Synchrony (SYF), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended December 2023.
Earnings Preview: Synchrony (SYF) Q4 Earnings Expected to Decline
by Zacks Equity Research
Synchrony (SYF) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Synchrony (SYF) Strengthens Ties to Offer Improved Health Care
by Zacks Equity Research
Synchrony (SYF) renews its deal with The Good Feet Store for providing flexible financing options, thereby encouraging customers to purchase more personalized arch supports from the latter.
Synchrony (SYF) Expands CareCredit Offering With Destination Pet
by Zacks Equity Research
Synchrony (SYF) partners with Destination Pet to offer financing solutions to pet owners through its CareCredit card.
Time to Buy OneMain Holdings (OMF) Stock for Higher Highs?
by Shaun Pruitt
OneMain Holdings' (OMF) valuation and lucrative dividend yield remain enticing to income investors with shares hovering near 52-week highs.
Time to Buy Ally or Synchrony Financial Stock for Higher Highs?
by Shaun Pruitt
Several consumer lending stocks have been bright spots in the financial sector with Ally Financial (ALLY) and Synchrony Financial (SYF) standing out in particular.
Why You Should Hold Synchrony (SYF) Stock in Your Portfolio
by Zacks Equity Research
Synchrony's (SYF) product innovations, partnerships and rising purchase volumes poise it well for growth.
Why Is PRA Group (PRAA) Up 21.6% Since Last Earnings Report?
by Zacks Equity Research
PRA Group (PRAA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Strength Seen in Primis Financial (FRST): Can Its 5.2% Jump Turn into More Strength?
by Zacks Equity Research
Primis Financial (FRST) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
Synchrony (SYF) & HABRI Join Forces to Boost Human-Animal Bond
by Zacks Equity Research
Synchrony (SYF) is expected to promote HABRI's science-based education within CareCredit's extensive veterinary network.
Synchrony (SYF) to Issue Co-Branded Card for J.Crew Clients
by Zacks Equity Research
Synchrony (SYF) ties up with J.Crew Group and Mastercard to introduce a consumer financing program and offer higher rewards for J.Crew customers.
Synchrony (SYF) Frees Up Capital With the Sale of Pets Best
by Zacks Equity Research
Synchrony's (SYF) divestiture of Pets Best is expected to free up capital and expand Care Credit's reach to pet owners.
Synchrony (SYF) Up 7.2% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Synchrony (SYF) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Synchrony (SYF) Joins Forces With Big Brand Tire & Service
by Zacks Equity Research
The new partnership will strategically expand Synchrony's (SYF) market reach in automotive financing.
Rithm Capital (RITM) Shares Up 10% Since Q3 Earnings Release
by Zacks Equity Research
Rithm Capital's (RITM) Q3 results indicate higher interest income and strong contribution from the Servicing segment, partly offset by an escalating expense base.
SYF vs. BX: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
SYF vs. BX: Which Stock Is the Better Value Option?
Synchrony (SYF) Q3 Earnings Beat on Growing Purchase Volume
by Zacks Equity Research
Synchrony (SYF) expects loan receivables to grow 11% for 2023, up from the previous guidance of 8-10%.
Synchrony (SYF) Reports Q3 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
Although the revenue and EPS for Synchrony (SYF) give a sense of how its business performed in the quarter ended September 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Synchrony (SYF) Beats Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Synchrony (SYF) delivered earnings and revenue surprises of 2.78% and 1.58%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
Will Rising Expenses Affect Synchrony's (SYF) Q3 Earnings?
by Zacks Equity Research
Synchrony's (SYF) third-quarter results are likely to reflect lower net interest margins and higher total average active accounts.
Moody's (MCO) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Moody's (MCO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Earnings Preview: Synchrony (SYF) Q3 Earnings Expected to Decline
by Zacks Equity Research
Synchrony (SYF) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Should Value Investors Buy Synchrony Financial (SYF) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Synchrony (SYF) & Veterinary Growth to Offer Pet Care Financing
by Zacks Equity Research
Synchrony (SYF) collaborates with Veterinary Growth to provide pet care financing solutions to its members.